Contrave vs GLP-1s: Which Weight Medication Fits Which Person?
Key takeaways
- GLP-1s target hunger volume; Contrave targets craving and reward eating.
- Averages favour GLP-1s (15 to 21 percent vs 5 to 9).
- Contrave and generic liraglutide form the budget lane.
- Different exclusion lists open different doors per patient.
- 16-week checkpoints govern switching either way.
The weight-medication conversation collapsed into GLP-1 or nothing, and that flattens a genuinely useful question: which tool fits which eater? Here is the practical Contrave-versus-GLP-1 decision guide prescribers actually walk through.
Two different problems, two different drugs
- GLP-1s mute hunger and slow the stomach: strongest for people driven by appetite volume and food noise.
- Contrave mutes reward and craving circuits: strongest for people who eat past fullness, at night, under stress: want without hunger.
The first diagnostic question is honest self-observation: am I hungry all the time, or am I pulled by food I do not need? Many people are both, which is why the decision has more inputs.
The comparison table that matters
- Average results: GLP-1s win clearly: 15 to 21 percent versus Contrave's 5 to 9.
- Form: pills twice daily versus weekly injection (or 2026's daily GLP-1 tablets: the form gap is closing).
- Cost: Contrave and generic liraglutide occupy the budget lane; premium GLP-1s dominate the price ceiling.
- Exclusions: Contrave's opioid and seizure rules versus GLP-1s' thyroid and pancreatitis history rules: different bodies get different doors.
- Side-effect flavour: head and sleep versus gut and nausea.
How the choice plays out in clinic
Typical patterns: craving-dominant eaters, opioid-free, with tight budgets or GLP-1 intolerance lean Contrave; volume-hungry eaters with coverage lean GLP-1; some cases combine mechanisms under specialist care. Non-response by each drug's checkpoint (16 weeks either way) triggers the switch conversation: the era of monogamous prescribing is over.
And both share the same fine print: results ride on protein, movement and sleep, and exits without habits invite regain.
The takeaway
GLP-1s are the stronger drug; Contrave is the cravings specialist and the budget contender. The right answer is a matching exercise, eater type, health history, wallet, not a ranking, and a prescriber who asks about your eating pattern is running exactly this playbook.
Frequently asked questions
Can Contrave and a GLP-1 be taken together?
Combination approaches exist under specialist supervision, but they are individualized medicine, not a standard stack to request.
Which is safer, Contrave or GLP-1s?
Neither universally: safety is personal. Opioid users and seizure histories exclude Contrave; certain thyroid and pancreatic histories exclude GLP-1s. Your chart decides.
Which works faster?
Both reveal themselves within roughly 16 weeks. GLP-1 appetite effects are often felt in days; Contrave's craving quieting builds over the ramp month.
Read next
- Weight-Loss Pens: Pros and Cons
The GLP-1 side of the scale.
- Contrave: How It Works
The cravings mechanism, unpacked.
- Qsymia Explained
The third contender in the pill lane.
This article is for general informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your individual situation, and never start or stop a medication without your doctor. See our Medical Disclaimer.